Selected research
Market Structure
Global Cardiovascular Interventional Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global top 5 players hold a market share over 70% in 2019. The key players are Boston Scientific Corporation, ABBOTT LABORATORIES, Medtronic, etc.
This report provides an overview of the global Cardiovascular Interventional Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cardiovascular Interventional Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
Read the full market overview
The report also presents Cardiovascular Interventional Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiovascular Interventional Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Cardiovascular Interventional Devices Segment by Company
Boston Scientific Corporation
ABBOTT LABORATORIES
Medtronic
Terumo manufacturers
NIPRO Medical Corporation
B. Braun Sharing Expertise
Cook medical
Microport
Lepumedical
Jwmedical
ASAHI INTECC
Kaneka Corporation
Sinomed
Lifetechmed
Gore
Cardiovascular Interventional Devices Segment by Type
Coronary artery stent
PTCA balloon catheter
thread
Other
Cardiovascular Interventional Devices Segment by Application
Angina pectoris
Myocardial infarction,
Other
Cardiovascular Interventional Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Interventional Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Interventional Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Interventional Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cardiovascular Interventional Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular Interventional Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiovascular Interventional Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cardiovascular Interventional Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Coronary artery stent
- PTCA balloon catheter
- thread
- Other
Applications
- Angina pectoris
- Myocardial infarction,
- Other
Companies covered
- Boston Scientific Corporation
- ABBOTT LABORATORIES
- Medtronic
- Terumo manufacturers
- NIPRO Medical Corporation
- B. Braun Sharing Expertise
- Cook medical
- Microport
- Lepumedical
- Jwmedical
- ASAHI INTECC
- Kaneka Corporation
- Sinomed
- Lifetechmed
- Gore
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cardiovascular Interventional Devices Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cardiovascular Interventional Devices Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cardiovascular Interventional Devices Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cardiovascular Interventional Devices Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cardiovascular Interventional Devices Market Dynamics
- 2.1 Cardiovascular Interventional Devices Industry Trends
- 2.2 Cardiovascular Interventional Devices Industry Drivers
- 2.3 Cardiovascular Interventional Devices Industry Opportunities and Challenges
- 2.4 Cardiovascular Interventional Devices Industry Restraints
3 Cardiovascular Interventional Devices Market by Manufacturers
- 3.1 Global Cardiovascular Interventional Devices Revenue by Manufacturers (2021-2026)
- 3.2 Global Cardiovascular Interventional Devices Sales by Manufacturers (2021-2026)
- 3.3 Global Cardiovascular Interventional Devices Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cardiovascular Interventional Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cardiovascular Interventional Devices Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cardiovascular Interventional Devices Manufacturers, Product Type & Application
- 3.7 Global Cardiovascular Interventional Devices Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cardiovascular Interventional Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cardiovascular Interventional Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Cardiovascular Interventional Devices Tier 1, Tier 2, and Tier 3
4 Cardiovascular Interventional Devices Market by Type
- 4.1 Cardiovascular Interventional Devices Type Introduction
- 4.1.1 Coronary artery stent
- 4.1.2 PTCA balloon catheter
- 4.1.3 thread
- 4.1.4 Other
- 4.2 Global Cardiovascular Interventional Devices Sales by Type
- 4.2.1 Global Cardiovascular Interventional Devices Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cardiovascular Interventional Devices Sales by Type (2021-2032)
- 4.2.3 Global Cardiovascular Interventional Devices Sales Market Share by Type (2021-2032)
- 4.3 Global Cardiovascular Interventional Devices Revenue by Type
- 4.3.1 Global Cardiovascular Interventional Devices Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cardiovascular Interventional Devices Revenue by Type (2021-2032)
- 4.3.3 Global Cardiovascular Interventional Devices Revenue Market Share by Type (2021-2032)
5 Cardiovascular Interventional Devices Market by Application
- 5.1 Cardiovascular Interventional Devices Application Introduction
- 5.1.1 Angina pectoris
- 5.1.2 Myocardial infarction,
- 5.1.3 Other
- 5.2 Global Cardiovascular Interventional Devices Sales by Application
- 5.2.1 Global Cardiovascular Interventional Devices Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cardiovascular Interventional Devices Sales by Application (2021-2032)
- 5.2.3 Global Cardiovascular Interventional Devices Sales Market Share by Application (2021-2032)
- 5.3 Global Cardiovascular Interventional Devices Revenue by Application
- 5.3.1 Global Cardiovascular Interventional Devices Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cardiovascular Interventional Devices Revenue by Application (2021-2032)
- 5.3.3 Global Cardiovascular Interventional Devices Revenue Market Share by Application (2021-2032)
6 Global Cardiovascular Interventional Devices Sales by Region
- 6.1 Global Cardiovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cardiovascular Interventional Devices Sales by Region (2021-2032)
- 6.2.1 Global Cardiovascular Interventional Devices Sales by Region (2021-2026)
- 6.2.2 Global Cardiovascular Interventional Devices Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cardiovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cardiovascular Interventional Devices Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cardiovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cardiovascular Interventional Devices Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cardiovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cardiovascular Interventional Devices Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cardiovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cardiovascular Interventional Devices Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cardiovascular Interventional Devices Revenue by Region
- 7.1 Global Cardiovascular Interventional Devices Revenue by Region
- 7.1.1 Global Cardiovascular Interventional Devices Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cardiovascular Interventional Devices Revenue by Region (2021-2026)
- 7.1.3 Global Cardiovascular Interventional Devices Revenue by Region (2027-2032)
- 7.1.4 Global Cardiovascular Interventional Devices Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cardiovascular Interventional Devices Revenue (2021-2032)
- 7.2.2 North America Cardiovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cardiovascular Interventional Devices Revenue (2021-2032)
- 7.3.2 Europe Cardiovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cardiovascular Interventional Devices Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cardiovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cardiovascular Interventional Devices Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cardiovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Boston Scientific Corporation
- 8.1.1 Boston Scientific Corporation Company Information
- 8.1.2 Boston Scientific Corporation Business Overview
- 8.1.3 Boston Scientific Corporation Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Boston Scientific Corporation Cardiovascular Interventional Devices Product Portfolio
- 8.1.5 Boston Scientific Corporation Recent Developments
- 8.2 ABBOTT LABORATORIES
- 8.2.1 ABBOTT LABORATORIES Company Information
- 8.2.2 ABBOTT LABORATORIES Business Overview
- 8.2.3 ABBOTT LABORATORIES Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 ABBOTT LABORATORIES Cardiovascular Interventional Devices Product Portfolio
- 8.2.5 ABBOTT LABORATORIES Recent Developments
- 8.3 Medtronic
- 8.3.1 Medtronic Company Information
- 8.3.2 Medtronic Business Overview
- 8.3.3 Medtronic Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Medtronic Cardiovascular Interventional Devices Product Portfolio
- 8.3.5 Medtronic Recent Developments
- 8.4 Terumo manufacturers
- 8.4.1 Terumo manufacturers Company Information
- 8.4.2 Terumo manufacturers Business Overview
- 8.4.3 Terumo manufacturers Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Terumo manufacturers Cardiovascular Interventional Devices Product Portfolio
- 8.4.5 Terumo manufacturers Recent Developments
- 8.5 NIPRO Medical Corporation
- 8.5.1 NIPRO Medical Corporation Company Information
- 8.5.2 NIPRO Medical Corporation Business Overview
- 8.5.3 NIPRO Medical Corporation Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 NIPRO Medical Corporation Cardiovascular Interventional Devices Product Portfolio
- 8.5.5 NIPRO Medical Corporation Recent Developments
- 8.6 B. Braun Sharing Expertise
- 8.6.1 B. Braun Sharing Expertise Company Information
- 8.6.2 B. Braun Sharing Expertise Business Overview
- 8.6.3 B. Braun Sharing Expertise Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 B. Braun Sharing Expertise Cardiovascular Interventional Devices Product Portfolio
- 8.6.5 B. Braun Sharing Expertise Recent Developments
- 8.7 Cook medical
- 8.7.1 Cook medical Company Information
- 8.7.2 Cook medical Business Overview
- 8.7.3 Cook medical Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Cook medical Cardiovascular Interventional Devices Product Portfolio
- 8.7.5 Cook medical Recent Developments
- 8.8 Microport
- 8.8.1 Microport Company Information
- 8.8.2 Microport Business Overview
- 8.8.3 Microport Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Microport Cardiovascular Interventional Devices Product Portfolio
- 8.8.5 Microport Recent Developments
- 8.9 Lepumedical
- 8.9.1 Lepumedical Company Information
- 8.9.2 Lepumedical Business Overview
- 8.9.3 Lepumedical Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Lepumedical Cardiovascular Interventional Devices Product Portfolio
- 8.9.5 Lepumedical Recent Developments
- 8.10 Jwmedical
- 8.10.1 Jwmedical Company Information
- 8.10.2 Jwmedical Business Overview
- 8.10.3 Jwmedical Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Jwmedical Cardiovascular Interventional Devices Product Portfolio
- 8.10.5 Jwmedical Recent Developments
- 8.11 ASAHI INTECC
- 8.11.1 ASAHI INTECC Company Information
- 8.11.2 ASAHI INTECC Business Overview
- 8.11.3 ASAHI INTECC Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 ASAHI INTECC Cardiovascular Interventional Devices Product Portfolio
- 8.11.5 ASAHI INTECC Recent Developments
- 8.12 Kaneka Corporation
- 8.12.1 Kaneka Corporation Company Information
- 8.12.2 Kaneka Corporation Business Overview
- 8.12.3 Kaneka Corporation Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Kaneka Corporation Cardiovascular Interventional Devices Product Portfolio
- 8.12.5 Kaneka Corporation Recent Developments
- 8.13 Sinomed
- 8.13.1 Sinomed Company Information
- 8.13.2 Sinomed Business Overview
- 8.13.3 Sinomed Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Sinomed Cardiovascular Interventional Devices Product Portfolio
- 8.13.5 Sinomed Recent Developments
- 8.14 Lifetechmed
- 8.14.1 Lifetechmed Company Information
- 8.14.2 Lifetechmed Business Overview
- 8.14.3 Lifetechmed Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Lifetechmed Cardiovascular Interventional Devices Product Portfolio
- 8.14.5 Lifetechmed Recent Developments
- 8.15 Gore
- 8.15.1 Gore Company Information
- 8.15.2 Gore Business Overview
- 8.15.3 Gore Cardiovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Gore Cardiovascular Interventional Devices Product Portfolio
- 8.15.5 Gore Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cardiovascular Interventional Devices Value Chain Analysis
- 9.1.1 Cardiovascular Interventional Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cardiovascular Interventional Devices Production Mode & Process
- 9.2 Cardiovascular Interventional Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cardiovascular Interventional Devices Distributors
- 9.2.3 Cardiovascular Interventional Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst